The table below shows INSMED Inc's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$935.01M
-$683.88M
-$536.25M
-$400.44M
-$363.30M
-$219.35M
Capital expenditure
$32.56M
$21.92M
$13.29M
$9.88M
$7.29M
$6.24M
Investing cash flow
-$64.58M
-$583.17M
-$223.60M
-$34.58M
-$64.28M
-$6.82M
Dividends paid
-
-
-
-
INSM operating cash flow (10-K history)
INSMED Inc reported operating cash flow of -$935.01M for fiscal year 2025. That is down 36.7% from -$683.88M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$146.71M (FY 2016) to -$935.01M. Figures come from the company's audited annual reports as filed with the SEC.